SPI Infoamtion

1. Cardiovascular Diseases
Deaths from Cardiovascular Diseases (CVD)
CVD Deaths Breakdown
CVD Prevalence

2. Congenital Heart Diseases Overview
2.1 Causes of Congenital Heart Defects
2.2 Common Congenital Defects
2.2.1 Structural Heart Defects

3. Global Congenital Heart Disease Market Size
Market Opportunity
Annual Cases of Congenital Heart Diseases

4. Market Segmentation of Congenital Heart Diseases
4.1 Atrial Septal Defect (ASD)
4.2 Ventricular Septal Defect (VSD)
4.3 Patent Foramen Ovale (PFO)
4.4 Left Atrial Appendage (LAA)
4.5 Patent Ductus Arteriosus (PDA)

5. Market Trends
5.1 Mortality Trend
5.2 Prevalence Rates of Congenital Cardiovascular Defects
5.3 Evolution of Diagnostic Methods
5.4 Risks Associated With Maternal Illness

6. Market Drivers
6.1 Rise in Survival of COHD Patients till Adulthood
6.2 Increasing Congenital Heart Defect Cases
6.3 New Diagnostic Techniques
6.4 Rising Consumer Income

7. Challenges
7.1 High Treatment Costs
7.2 Less Number of Medical Practitioners

8. Competitive Landscape

9. Company Profiles
9.1 AGA Medical
Business Description
Business Strategies
Organic Growth through New Product Introductions
Capitalize on the PFO Market Opportunity
Expand and Commercialize Research and Development Pipeline
Continue to Strengthen Global Distribution

9.2 NMT Medical
Business Description
Business Strategies
Continue to Strengthen Global Distribution
Expand Market Share in High Growth Regions

9.3 St. Jude Medical
Business Description
Business Strategies
Acquisition Strategy
Focus on Cardiovascular Segment

List of Graphs:
Deaths from Cardiovascular Diseases in the U.S
Breakdown of Deaths from CVD in the U.S
Prevalence of CVD in Adults by Age and Sex, U.S
Diagnosis of Congenital Heart Disease by Age (2008)
Worldwide Market Opportunity for Congenital Heart Diseases (2005E-2012E)
Estimated Global annual Cases of Congenital Heart Defects (2005E-2012E)
Estimated Worldwide Market Opportunity for ASD (2005E-2010E)
Estimated Worldwide Market Opportunity for VSD (2005E-2010E)
Total Annual VSD Interventions Worldwide (2005E-2012E)
Estimated Worldwide Market Opportunity for PFO (2008E-2015E)
Estimated Total PFO Treatable Population (2008E-2015E)
Estimated Worldwide Market Opportunity for PDA (2005E-2011E)
Hospital Discharge Mortality Rate in the U.S (2004-2007)
Patients Reaching Adulthood with Congenital Heart Disease Globally (1970-2010E)
Estimated Worldwide Population with Congenital Heart Disease (2005E-2012E)
World Gross National Income Per Capita by Region (2001-2008)
Revenue of AGA Medical (2005 -2009)
Revenue of NMT Medical (2005 -2009)
Revenue of St. Jude Medical (2005 -2009)

List of Tables:
Age adjusted Prevalence Estimates (2008)
Occurrence of Common Congenital Heart Defects
Market Potential for Structural Heart Defects (2009)
Estimated Global Market Opportunity for ASD Closure Devices (2008)
Cryptogenic Stroke PFO Closure Annual Market Opportunity (2009)
Migraine PFO Closure Annual Market Opportunity (2009)
Left Atrial Appendage Occlusion Annual Market Opportunity (2009)
Mortality from Congenital Heart Defects, U.S (2006)
Prevalence rates for Congenital Heart Defects and Associated Clinical Characteristics
Exposure Associated with Definitive or Possible Risk of Offspring with COHD (2007)
Estimated Direct and Indirect Costs for Various Treatments in the U.S (2010)
Current Competitive Landscape for Structural Heart Repair (2009)